18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing

Why the setting decides which license you open

Quick Answer: An out-of-state pharmacy that ships, mails, or delivers legend drugs or devices into Connecticut pursuant to a prescription is a nonresident pharmacy. It needs a CGS § 20-627 certificate before § 20-628 allows the shipment. Keep a valid home-state license, report changes within ten days, and staff a toll-free pharmacist line at least six days and 40 hours per week with the number on the label. Hospital sterile remote supervision is CGS § 20-609a (audio and video). Nuclear practice needs a nuclear pharmacist who supervises only one nuclear pharmacy (RCSA § 20-576-61). Nursing-home cabinets are § 20-621a. Wholesalers hold CGS § 21a-70, not a § 20-594 pharmacy license.

NABP Competency 4.7 is not “every building with a mortar-and-pestle logo is a community pharmacy.” Connecticut writes different credentials for mail-order, hospital, nuclear, automated cabinets, and wholesale. Using the wrong noun is the item.

Nonresident pharmacy — CGS §§ 20-627 to 20-630

§ 20-627(a) defines nonresident pharmacy as any pharmacy located outside this state that ships, mails, or delivers, in any manner, legend devices or legend drugs into this state pursuant to a prescription order. § 20-628 then makes the credential mandatory: no nonresident pharmacy shall engage in that shipping business unless it has been issued a certificate of registration and has paid the § 20-601 issuance or renewal fee.

§ 20-601(12)–(13) set those fees at $750 to issue and $190 to renew — the same dollars as an in-state pharmacy license. DCP’s Pharmacy License Outside the State of Connecticut page expires nonresident credentials annually on August 31, requires a current home-state registration, a DEA registration copy, and the most recent inspection, and routes email to DCP.PharmacyNRLicense@ct.gov. The Commission reviews the file. DCP’s FAQ describes a typical complete-file review of about 60 days in pending status; that operational estimate is not a statutory deadline.

§ 20-627(b) is the ongoing compliance list the MPJE actually grades:

• Annual report to the Commission: location, names and titles of principal corporate officers (if applicable), and all pharmacists dispensing drugs or devices to Connecticut residents.
• Report within ten days after any change of name, ownership, management, officers, or directors, with the § 20-601 filing fee; miss ten days and pay the late fee. (DCP’s nonresident FAQ still describes some change filings as “within thirty days.” Prefer the statute’s ten-day clock if the item asks what the law requires.)
• Comply with lawful directions and requests for information from Connecticut regulators.
• Disclose whether the nonresident pharmacy is dispensing sterile pharmaceuticals, as defined in § 20-633b, within this state. If a dispensed sterile pharmaceutical is not patient-specific, submit a copy of the home-state manufacturing license or registration and any FDA registration — the same 503B / § 21a-70 overlay Chapter 17 taught.
• Maintain at all times a valid, unexpired license, permit, or registration to conduct the pharmacy in the home state.
• Before receiving the Connecticut certificate, submit a copy of the most recent inspection by the home-state agency. If the pharmacy will deliver sterile compounded products into Connecticut, that report must include a USP <797> section; if the home state does not inspect to <797>, the pharmacy must still prove <797> compliance to DCP.
• Notify DCP of any disciplinary action, written advisement, or warning by a federal or state regulator or accreditation body not later than ten business days after being notified.
• After initiating a recall, provide DCP the names and addresses of all Connecticut residents who received the recalled legend drugs or devices not later than 24 hours later.

§ 20-627(c) is the counseling rule mail-order items quote: during regular hours of operation, but not less than six days per week and for a minimum of forty hours per week, provide a toll-free telephone number so Connecticut patients can reach a pharmacist at that nonresident pharmacy who has access to the patient’s records. Print that number on a label affixed to each container dispensed to a Connecticut patient. A voicemail box that opens three weekday afternoons is not subsection (c).

Connecticut law applies to the drugs shipped in. Registration is not a waiver of Connecticut sterile-addendum, recall, substitution, or controlled-substance rules that attach to the product once it is intended for a Connecticut patient. Home-state “we already counsel under New Jersey hours” does not shrink the six-day / 40-hour Connecticut line.

Hospital and institutional practice versus retail

CGS § 20-571 distinguishes an institutional pharmacy (and a health care institutional pharmacy) from a community store that primarily serves noninstitutionalized patients. P.A. 23-19 expressly lets a health care institution apply under § 20-594. A hospital pharmacy serving that hospital’s patients is not a retail hours-and-substitution counter, and § 20-633b preserves a licensed hospital’s ability to compound sterile products for that hospital’s patients consistent with federal law — not a license to mail CSPs across town as 503A retail fills.

CGS § 20-609a is the hospital electronic technology / telepharmacy statute. It lets the hospital use electronic technology at the hospital, its satellite, or remote locations so a pharmacist may supervise pharmacy technicians in the dispensing of sterile products. Teach the operational limits the exam uses:

• All orders for sterile products to be dispensed using telepharmacy shall be verified by a pharmacist before they are delegated to a technician.
• Supervision is through audio and video communication, not a pager or an email after the bag is gone.
• A hospital using telepharmacy shall undertake periodic quality-assurance evaluations not less than once per calendar quarter.

That is not a community remote-dispensing kiosk statute. Do not staff a strip-mall store with a camera and call it § 20-609a.

Nuclear pharmacy — RCSA §§ 20-576-60 to 20-576-63

RCSA § 20-576-60 defines a nuclear pharmacy as a pharmacy that provides radiopharmaceutical services and holds a Connecticut pharmacy license. A nuclear pharmacist (or authorized nuclear pharmacist) holds a current Connecticut pharmacist license and either Board of Pharmaceutical Specialties nuclear certification or identification as an authorized nuclear pharmacist on an NRC or agreement-state license that authorizes radioactive material in the practice of nuclear pharmacy.

RCSA § 20-576-61 then adds the license overlay:

• A license to operate a nuclear pharmacy is issued only to a person who is, or who employs, a nuclear pharmacist.
• That nuclear pharmacist is responsible for all operations, may supervise the operation of only one nuclear pharmacy, and shall be present at all times that radiopharmaceutical services are being performed and at all times the nuclear pharmacy is open for business.
• The nuclear-pharmacy license is effective only if the pharmacy also holds the appropriate federal and state licenses and permits to possess and distribute radioactive materials.
• Required space includes a preparation and dispensing area, a shipping and receiving area, a storage area, and a radioactive waste decay area, secured from unauthorized entry.
• Dispense radiopharmaceuticals only on an order from a licensed practitioner (or agent) or a person authorized by NRC or an agreement state to possess them.

An NRC materials license without a Connecticut pharmacy license, or a community manager “covering” two nuclear sites, fails § 20-576-61.

Automated dispensing and wholesale

CGS § 20-571 defines an automated prescription dispensing machine as a device and software, operated by a pharmacy or a § 20-627 nonresident pharmacy, in a nursing home or skilled nursing facility, that packages and labels patient-specific medication (or multiple medications) for administration by an RN or LPN based on a prescription that has already completed final verification by a licensed pharmacist. CGS § 20-621a authorizes a long-term care pharmacy to operate that machine in accordance with a protocol approved in writing by DCP. The annual fee is $100 per machine. The cabinet does not replace the pharmacist’s final check, and it is not a second community pharmacy the manager can “cover.”

Hospital floor cabinets used under pharmacist supervision for sterile products sit on § 20-609a when the supervision is remote electronic technology; they do not convert a community store into a hospital.

Wholesale distributors are licensed by DCP under CGS § 21a-70. DCP’s wholesaler pages register firms that supply controlled substances, legend drugs, OTC drugs, medical devices, or cosmetics to other wholesalers, manufacturers, practitioners, hospitals, pharmacies, and retailers. In-state locations that store those articles must be separately registered. Current DCP fee bands are $190 without controlled substances and $375 with controlled substances (initial and renewal). A § 20-594 pharmacy license is not a wholesaler certificate, and a § 21a-70 certificate is not authority to operate a retail prescription department. Chapter 17 already attached § 21a-70 to non-patient-specific sterile stock; here the exam point is the credential on the warehouse.

Realistic Connecticut scenarios

A Florida mail-order pharmacy starts sending 90-day fills to Stamford without a § 20-627 certificate because “we are licensed in Florida and DEA-registered.” § 20-628 stops that shipment. After registration, a Tuesday-only callback line still fails § 20-627(c).

A community chain points a camera at a technician filling IV syringes in a medical-office closet and cites § 20-609a. That section is a hospital sterile-telepharmacy tool with prior pharmacist verification, audio and video, and quarterly QA — not a retail loophole.

Official anchors

• CGS § 20-627 and § 20-628 — definition, registration duties, counseling hours, shipping ban.
• DCP Pharmacy License Outside Connecticut — $750 / $190, August 31.
• CGS § 20-609a — hospital telepharmacy; quarterly QA.
• RCSA § 20-576-61 — nuclear pharmacist, one site, presence rule.
• CGS § 20-621a — nursing-home automated machine, $100/machine.
• DCP wholesalers — § 21a-70 credential and CS fee split.